ArticleClinical and experimental nephrology2017

Long-term treatment with EGFR inhibitor erlotinib attenuates renal inflammatory cytokines but not nephropathy in Alport syndrome mouse model.

Kohei Omachi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.